2Strauss GM. Role of chemotherapy in stages I to Ⅲ non-small cell lung cancer. Chest,1999,116:509s-516s. 被引量：1
3Brugger W, Fetscher S, Hasse J, et al. Multimodality treatment including early high-dose chemotherapy with peripheral blood stem cell transplantation in limited-disease small cell lung cancer. Semin Oncol,1998,25(Suppl 2):42s-48s. 被引量：1
4Kosmidis PA.A randomized phase III trial of paclitaxel plus carboplatin versus paclitaxel plus gemcitabine in advanced non-small cell lung cancer:a preliminary analysis.Lung Cancer,2000,29(Supp l2):147s. 被引量：1
5Comella P,Frasci G,Panza N,et al. Randomized trial comparing cisplatin,gemcitabine and vinorelbine with either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non-small cell lung cancer:interim analysis of a phase Ⅲ trial of the Southern Ltaly Co-operative Oncology Group.J Clin Ocnol,2000,18:1451-1457. 被引量：1
6Murphy GP,Tjoa BA,Simmon SJ,et al. Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: a phase II prostate cancer vaccine trial involving patients with hormone refractory metastatic disease.Prostate,1999,38:73-78. 被引量：1
7Swisher SG, Roth JA, Nemunaitis J, et al. Adenovirus-mediated p53 gene transfer in advanced non-small cell lung cancer.J Natl Cancer Inst,1999,91:763-771. 被引量：1
